141 related articles for article (PubMed ID: 35647142)
1. Anti-programmed death 1 antibody in the treatment of coexistent
Zhang CC; Chen P
World J Clin Cases; 2022 Apr; 10(12):3801-3807. PubMed ID: 35647142
[TBL] [Abstract][Full Text] [Related]
2. Natural history of Mycobacterium fortuitum pulmonary infection presenting with migratory infiltrates: a case report with microbiological analysis.
Okamori S; Asakura T; Nishimura T; Tamizu E; Ishii M; Yoshida M; Fukano H; Hayashi Y; Fujita M; Hoshino Y; Betsuyaku T; Hasegawa N
BMC Infect Dis; 2018 Jan; 18(1):1. PubMed ID: 29291713
[TBL] [Abstract][Full Text] [Related]
3. Nontuberculous mycobacteria isolated during the treatment of pulmonary tuberculosis.
Jun HJ; Jeon K; Um SW; Kwon OJ; Lee NY; Koh WJ
Respir Med; 2009 Dec; 103(12):1936-40. PubMed ID: 19576745
[TBL] [Abstract][Full Text] [Related]
4. Exacerbation of nontuberculous mycobacterial pulmonary disease in a patient with advanced non-small-cell lung cancer during treatment with PD-1 inhibitor and chemotherapy.
Okamoto M; Kim YH; Ouchi A; Yamaoka T; Iwamoto N; Iwatsubo S; Matsumura K; Nakamura M; Kin Y; Shiina Y; Funada Y
Respir Med Case Rep; 2021; 34():101529. PubMed ID: 34745866
[TBL] [Abstract][Full Text] [Related]
5. Clinical presentations of nontuberculous mycobacteria as suspected and drug-resistant tuberculosis: Experience from a tertiary care center in Eastern India.
Das S; Mishra B; Mohapatra PR; Preetam C; Rath S
Int J Mycobacteriol; 2022; 11(2):167-174. PubMed ID: 35775549
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of nontuberculous mycobacteria and high efficacy of d-cycloserine and its synergistic effect with clarithromycin against
Khosravi AD; Mirsaeidi M; Farahani A; Tabandeh MR; Mohajeri P; Shoja S; Hoseini Lar KhosroShahi SR
Infect Drug Resist; 2018; 11():2521-2532. PubMed ID: 30573983
[TBL] [Abstract][Full Text] [Related]
7. Successful bedaquiline-containing antimycobacterial treatment in post-traumatic skin and soft-tissue infection by Mycobacterium fortuitum complex: a case report.
Erber J; Weidlich S; Tschaikowsky T; Rothe K; Schmid RM; Schneider J; Spinner CD
BMC Infect Dis; 2020 May; 20(1):365. PubMed ID: 32448204
[TBL] [Abstract][Full Text] [Related]
8. A Case of Generalized, Superinfected Dermatitis and Inguinal Mycobacterium Lymphadenitis - TB or not TB?
Rotaru M; Marchian S; Fekete GL; Mariana Iancu GM
Acta Dermatovenerol Croat; 2018 Oct; 26(3):270-272. PubMed ID: 30390733
[TBL] [Abstract][Full Text] [Related]
9. Molecular Identification of Non-tuberculous Mycobacteria in Suspected Tuberculosis Cases in Central India.
Dadheech M; Malhotra AG; Patel S; Singh J; Khadanga S; Khurana A; Purwar S; Biswas D; Singh S; Maurya AK
Cureus; 2023 Jun; 15(6):e39992. PubMed ID: 37416024
[TBL] [Abstract][Full Text] [Related]
10. Disseminated Coinfection by
Huang H; Deng J; Qin C; Zhou J; Duan M
Infect Drug Resist; 2021; 14():3619-3625. PubMed ID: 34526784
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and speciation of non-tuberculous mycobacteria among pulmonary and extrapulmonary tuberculosis suspects in South India.
Thangavelu K; Krishnakumariamma K; Pallam G; Dharm Prakash D; Chandrashekar L; Kalaiarasan E; Das S; Muthuraj M; Joseph NM
J Infect Public Health; 2021 Mar; 14(3):320-323. PubMed ID: 33618276
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study on development of nontuberculous mycobacterial lung disease].
Kurashima A
Kekkaku; 2004 Dec; 79(12):737-41. PubMed ID: 15782619
[TBL] [Abstract][Full Text] [Related]
13. Species and genotypic diversity of non-tuberculous mycobacteria isolated from children investigated for pulmonary tuberculosis in rural Uganda.
Asiimwe BB; Bagyenzi GB; Ssengooba W; Mumbowa F; Mboowa G; Wajja A; Mayanja-Kiiza H; Musoke PM; Wobudeya E; Kallenius G; Joloba ML
BMC Infect Dis; 2013 Feb; 13():88. PubMed ID: 23413873
[TBL] [Abstract][Full Text] [Related]
14. Ocular mycobacteriosis-dual infection of M. tuberculosis complex with M. fortuitum and M. bovis.
Sharma K; Gautam N; Sharma M; Dogra M; Bajgai P; Tigari B; Sharma A; Gupta V; Sharma SP; Singh R
J Ophthalmic Inflamm Infect; 2017 Dec; 7(1):2. PubMed ID: 28091937
[TBL] [Abstract][Full Text] [Related]
15. Profile of patients with pulmonary non-tuberculous mycobacterial disease mimicking pulmonary tuberculosis.
Gomathy NS; Padmapriyadarsini C; Silambuchelvi K; Nabila A; Tamizhselvan M; Banurekha VV; Lavanya J; Chandrasekar C
Indian J Tuberc; 2019 Oct; 66(4):461-467. PubMed ID: 31813432
[TBL] [Abstract][Full Text] [Related]
16. Septicemia and pneumonia due to Mycobacterium fortuitum infection in a patient with extronodal NK/T-cell lymphoma, nasal type: A case report.
Cong J; Wang C; Ma L; Zhang S; Wang J
Medicine (Baltimore); 2017 May; 96(18):e6800. PubMed ID: 28471978
[TBL] [Abstract][Full Text] [Related]
17. The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.
Wang MS; Wang JL; Wang XF
BMC Pulm Med; 2016 Nov; 16(1):163. PubMed ID: 27887611
[TBL] [Abstract][Full Text] [Related]
18. The Presence of Coexisting Lung Cancer and Non-Tuberculous Mycobacterium in a Solitary Mass.
Taira N; Kawasaki H; Takahara S; Chibana K; Atsumi E; Kawabata T
Am J Case Rep; 2018 Jun; 19():748-751. PubMed ID: 29941862
[TBL] [Abstract][Full Text] [Related]
19. [Pituitary immune-related adverse events induced by programmed cell death protein 1 inhibitors in advanced lung cancer patients: A report of 3 cases].
Gu YC; Liu Y; Xie C; Cao BS
Beijing Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 54(2):369-375. PubMed ID: 35435206
[TBL] [Abstract][Full Text] [Related]
20. Nontuberculous mycobacteria isolation from sputum specimens: A retrospective analysis of 1061 cases.
Babalik A; Koç EN; Sekerbey HG; Dönmez GE; Balikci A; Kilicaslan Z
Int J Mycobacteriol; 2023; 12(1):55-65. PubMed ID: 36926764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
